|
Market Closed -
Hong Kong S.E.
04:08:27 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 81.55 HKD | +2.45% |
|
+3.89% | +52.57% |
Company Valuation: Keymed Biosciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,862 | 12,538 | 12,332 | 8,002 | 14,150 | 20,537 | - | - |
| Change | - | 59.47% | -1.64% | -35.11% | 76.82% | 45.14% | - | - |
| Enterprise Value (EV) 1 | 4,377 | 12,056 | 11,500 | 8,337 | 13,314 | 19,414 | 19,602 | 19,429 |
| Change | - | 175.43% | -4.61% | -27.5% | 59.69% | 45.82% | 0.97% | -0.88% |
| P/E | -1.16x | -38.2x | -32.5x | -14.7x | -25.1x | 25.5x | 1,434x | 57.2x |
| PBR | 2.15x | 3.75x | 4.13x | 3.28x | 4.74x | 5.78x | 5.8x | 5.31x |
| PEG | - | 0.4x | -2x | -0.3x | 8.24x | -0x | -14.6x | 0x |
| Capitalization / Revenue | 71.3x | 125x | 34.8x | 18.7x | 19.8x | 12.2x | 9.57x | 6.98x |
| EV / Revenue | 39.7x | 120x | 32.5x | 19.5x | 18.6x | 11.5x | 9.13x | 6.6x |
| EV / EBITDA | -10.9x | -46.5x | -42.6x | -21x | -32.8x | 33.8x | 122x | 44.2x |
| EV / EBIT | -10.5x | -22.1x | -25.1x | -17x | -26.4x | 61.1x | 887x | 62.7x |
| EV / FCF | -11.3x | -17.7x | -18.2x | -8.36x | -12.7x | 20.6x | -80.6x | 175x |
| FCF Yield | -8.83% | -5.65% | -5.49% | -12% | -7.86% | 4.85% | -1.24% | 0.57% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -24.17 | -1.18 | -1.37 | -1.97 | -1.91 | 2.732 | 0.0486 | 1.218 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 110.3 | 100.1 | 354.1 | 428.1 | 716.3 | 1,682 | 2,146 | 2,942 |
| EBITDA 1 | -402.3 | -259.1 | -269.8 | -397 | -405.8 | 574.6 | 160.4 | 439.4 |
| EBIT 1 | -415.2 | -544.5 | -457.4 | -490.2 | -503.8 | 317.9 | 22.1 | 309.7 |
| Net income 1 | -3,887 | -308.1 | -359.4 | -515.2 | -522.6 | 672.5 | -14.18 | 346.5 |
| Net Debt 1 | -3,485 | -482.1 | -831.6 | 334.8 | -836.4 | -1,123 | -935.1 | -1,108 |
| Reference price 2 | 28.11 | 45.11 | 44.57 | 29.04 | 48.03 | 69.71 | 69.71 | 69.71 |
| Nbr of stocks (in thousands) | 279,736 | 277,920 | 276,696 | 275,600 | 294,600 | 294,600 | - | - |
| Announcement Date | 3/29/22 | 3/17/23 | 3/26/24 | 3/24/25 | 3/26/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.51x | 11.54x | 33.79x | -.--% | 3.06B | |
| 21.73x | 7.77x | 15.61x | 1.37% | 74.46B | |
| 31.25x | 9.01x | 28.06x | 0.04% | 60.14B | |
| 33.64x | 6.03x | 18.07x | 0.97% | 48.15B | |
| 34.63x | 3.34x | 14.4x | -.--% | 44.25B | |
| -21.16x | 229.18x | -22.81x | -.--% | 43.99B | |
| 47.94x | 5.54x | 30.43x | -.--% | 41.61B | |
| 26.89x | 7.76x | 19.96x | 0.42% | 29.97B | |
| 33.91x | 7.26x | 18.84x | -.--% | 29.31B | |
| -70.02x | 13.44x | -68.51x | -.--% | 24.93B | |
| Average | 16.43x | 30.09x | 8.78x | 0.28% | 39.99B | |
| Weighted average by Cap. | 19.62x | 31.73x | 10.42x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2162 Stock
- Valuation Keymed Biosciences Inc.
Select your edition
All financial news and data tailored to specific country editions
